John J Mcnamara MD
Chronic Lung Disease of Prematurity and Infancy, Cystic Fibrosis Pulmonology, Pediatric Bronchoscopy
MD
Join to View Full Profile
2530 Chicago AveSte 400Minneapolis, MN 55404
Phone+1 612-813-3300
Fax+1 612-813-3349
Dr. Mcnamara is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. John McNamara is a pediatric pulmonologist based in Minneapolis, MN, with subspecialties in chronic lung disease of prematurity and infancy, cystic fibrosis pulmonology, and pediatric bronchoscopy. He earned his medical degree from the University of Florida College of Medicine in 1980 and completed his residency in pediatrics at the University of Rochester. Dr. McNamara has contributed to the field with multiple publications, including studies in well-regarded journals such as the American Journal of Respiratory Cell and Molecular Biology and The Lancet Respiratory Medicine. His work explores areas like CFTR function, safety of cystic fibrosis therapies, and therapy adherence among pediatric subjects. He is involved in clinical trials like the Baby Observational and Nutritional Study and is engaged in research focused on cystic fibrosis and related therapies.
Education & Training
University of Rochester Medical CenterResidency, Pediatrics, 1980 - 1983
University of Florida College of MedicineClass of 1980
Certifications & Licensure
MN State Medical License 1989 - 2025
WI State Medical License 1992 - 2003
American Board of Pediatrics Pediatrics- American Board of Pediatrics Pediatric Pulmonology
Clinical Trials
- Treatment of Anxiety/Depression and Pain Through Relaxation Yoga for Patient With Cystic Fibrosis (CF) Start of enrollment: 2010 Mar 01
- Early Methicillin-resistant Staphylococcus Aureus (MRSA) Therapy in Cystic Fibrosis (CF) Start of enrollment: 2011 Apr 01
- Baby Observational and Nutritional Study Start of enrollment: 2011 Dec 01
Publications & Presentations
PubMed
- 1 citationsInvestigation of CFTR Function in Human Nasal Epithelial Cells Informs Personalized Medicine.Audrey Pion, Erin Kavanagh, Anya T Joynt, Karen S Raraigh, Lori Vanscoy
American Journal of Respiratory Cell and Molecular Biology. 2024-11-01 - 25 citationsLong-term safety of lumacaftor-ivacaftor in children aged 2-5 years with cystic fibrosis homozygous for the F508del-CFTR mutation: a multicentre, phase 3, open-label, ...Jordana E. Hoppe, Mark A. Chilvers, Felix Ratjen, John McNamara, Caroline A. Owen
The Lancet. Respiratory Medicine. 2021-05-06 - 27 citationsLong-term safety and efficacy of tezacaftor–ivacaftor in individuals with cystic fibrosis aged 12 years or older who are homozygous or heterozygous for Phe508del CFTR ...Patrick A. Flume, Reta Fischer Biner, Damian G Downey, Cynthia A. Brown, Manu Jain
The Lancet. Respiratory Medicine. 2021-02-10
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
